1,898.5
+5.09%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About M3
Its shares trade on Tokyo Stock Exchange under the ticker 2413.T. It has been listed since 16 September 2004. In the fiscal year to 31 March 2026, it reported revenue of ¥351.36bn and net income of ¥49.10bn. At that date it held total assets of ¥637.40bn and shareholders' equity of ¥408.22bn.
M3, Inc. engages in the provision of medical related services through the Internet. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2004-09-16. The firm has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is involved in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 16 Sept 2004
- Employees
- 7,127
- Website
- corporate.m3.com ↗
Leadership
Pay as last reported
- Mr. Itaru TanimuraPresident, Representative Director, since 2000
- Mr. Rie NakamuraPresident of Subsidiary, Director, since 2022
- Mr. Hirofumi OhbaExecutive Officer
- Mr. Yoshinao TanakaDirector, since 2016
- Mr. Akihiko TomaruDirector¥42.0m
- Mr. Eiji TsuchiyaDirector, since 2012
- Mr. Satoshi YamazakiDirector, since 2019
- Ms. Takako EbataIndependent Director
- Ms. Satoko SuzukiIndependent Director
- Mr. Yusuke TsugawaIndependent Director
- Ms. Mayuka YamazakiIndependent Director
- Mr. Kenichiro YoshidaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 52
- Environment
- 19
- Social
- 82
- Governance
- 56
- Direct emissions (scope 1)
- 0 t
- Energy emissions (scope 2)
- 180.264 t
- Women in the workforce
- 57%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- M3 Inc is a prominent player in the digital healthcare industry, providing innovative solutions and services to healthcare professionals and patients. Its advanced technology platforms enable efficient communication, medical research, and healthcare delivery, leading to improved patient outcomes.
- M3 Inc holds a strong market position in various regions, backed by its extensive network of healthcare professionals and partnerships with pharmaceutical companies. This allows the company to attract a large user base for its digital healthcare platforms and expand its market share.
Weaknesses
- M3 Inc's primary market is Japan, which makes it vulnerable to fluctuations in the domestic market. Dependent on a single market exposes the company to risks associated with economic downturns, regulatory changes, or intense competition in Japan's healthcare sector.
- Despite its strong presence in Japan, M3 Inc's global footprint is relatively limited. Expanding into international markets may require overcoming regulatory barriers, cultural differences, and building brand awareness, which can pose challenges and slow down their growth outside of Japan.
Opportunities
- The increasing adoption of digital health solutions presents a significant growth opportunity for M3 Inc. The demand for efficient healthcare communication, telemedicine, and remote patient monitoring continues to rise globally. M3 Inc can leverage its expertise and technological capabilities to address these market needs and expand its customer base.
- Collaborating with healthcare providers and institutions can open avenues for M3 Inc to offer integrated services and drive customer loyalty. By partnering with hospitals, clinics, and medical research organizations, M3 Inc can enhance its product offerings, gather valuable data insights, and establish long-term relationships within the healthcare ecosystem.
Threats
- The digital healthcare sector is highly competitive, with numerous players vying for market share. M3 Inc faces the threat of new entrants, existing competitors, and potential technological disruptions. To maintain its competitive edge, M3 Inc needs to continuously innovate and provide superior products and services compared to its rivals.
- The digital healthcare industry is subject to evolving regulations and compliance requirements. M3 Inc must stay up-to-date with these changes and ensure its platforms align with regulatory standards. Any failure to comply may result in legal consequences, loss of trust from customers, and damage to the company's reputation.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.